Progressive Ventricular Dysfunction Prevention in Pacemaker Patients
Spain108 participantsStarted 2002-01
Plain-language summary
The purpose of this pilot study is to evaluate the progression of ventricular dysfunction in patients with ventricular dysfunction within the permanent pacing population.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Meet Class I and/or Class IIa implantation criteria for permanent cardiac pacing according to the guidelines given by the American College of Cardiology (ACC)/American Heart Association(AHA).
Exclusion Criteria:
* Expected ventricle stimulation \<80% of the time
* Impossibility of dual chamber stimulation in the absence of AF
* Severe heart failure (NYHA Functional class III-IV) previous to indication for pacing device implant
* Patient needs revascularization within 3 months
* Myocardial infarction in the last 3 months
* Cardiac surgery performed in the last 3 months
* Hypertrophic cardiomyopathy
* Constrictive pericarditis
* Bad echo window
* Previous system implanted (ICD or pacemaker)
* Aortic stenosis
* Patient has a mechanical right heart valve
* Patient \<18 years
* Pregnancy
* Patient has medical conditions that would preclude the testing required by the protocol, or limit study participation
* Life expectancy \<1year
* Patient is unwilling or unable to cooperate or give written informed consent.
* Patient is or will be inaccessible for follow-up at the study center.
* Patients who are participating or planning to participate in other clinical trials during the clinical study
What they're measuring
1
Evolution of the ejection fraction (EF) of the left ventricle (LV) and the ventricular volumes.